4//SEC Filing
Kelsey Stephen Michael 4
Accession 0001610717-25-000077
CIK 0001628171other
Filed
Mar 18, 8:00 PM ET
Accepted
Mar 19, 5:40 PM ET
Size
4.8 KB
Accession
0001610717-25-000077
Insider Transaction Report
Form 4
Kelsey Stephen Michael
See Remarks
Transactions
- Sale
Common Stock
2025-03-17$39.04/sh−3,294$128,599→ 293,051 total
Footnotes (2)
- [F1]Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units ("RSUs") after July 15, 2023.
- [F2]Includes 104,850 RSUs.
Documents
Issuer
Revolution Medicines, Inc.
CIK 0001628171
Entity typeother
Related Parties
1- filerCIK 0001462808
Filing Metadata
- Form type
- 4
- Filed
- Mar 18, 8:00 PM ET
- Accepted
- Mar 19, 5:40 PM ET
- Size
- 4.8 KB